{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T21:11:28Z","timestamp":1760735488298,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejca.2021.03.022","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T05:30:41Z","timestamp":1619155841000},"page":"130-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Combination of targeted therapy and immune checkpoint blocker in a patient with xeroderma pigmentosum presenting an aggressive angiosarcoma and a recurrent non-resectable basal cell carcinoma"],"prefix":"10.1016","volume":"150","author":[{"given":"Celine","family":"Boutros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etienne","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Majer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Robert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.03.022_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1750-1172-6-70","article-title":"Xeroderma pigmentosum","volume":"6","author":"Lehmann","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ejca.2021.03.022_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejca.2017.06.022","article-title":"Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: case report and review of the literature","volume":"83","author":"Deinlein","year":"2017","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.03.022_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejca.2017.02.026","article-title":"Regression of melanoma metastases and multiple non-melanoma skin cancers in xeroderma pigmentosum by the PD1-antibody pembrolizumab","volume":"77","author":"Hauschild","year":"2017","journal-title":"Eur J Canc"},{"issue":"5","key":"10.1016\/j.ejca.2021.03.022_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a004408","article-title":"Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage disease","volume":"5","author":"Momen","year":"2019","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"5","key":"10.1016\/j.ejca.2021.03.022_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/phpp.12391","article-title":"Angiosarcoma arising on the scalp in a Korean patient with xeroderma pigmentosum variant type","volume":"34","author":"Hong","year":"2018","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"1","key":"10.1016\/j.ejca.2021.03.022_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1365-2133.1999.02947.x","article-title":"Angiosarcoma of the head and neck associated with xeroderma pigmentosum variant","volume":"141","author":"De Silva","year":"1999","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.ejca.2021.03.022_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1470-2045(18)30006-8","article-title":"A non-comparative multi-center randomized phase II study of nivolumab +\/\u2212 ipilimumab for patients with metastatic sarcoma (Alliance A091401)","volume":"19","author":"D'Angelo","year":"2018","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2021.03.022_bib8","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1172\/JCI84940","article-title":"Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer","volume":"126","author":"Mehnert","year":"2016","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ejca.2021.03.022_bib9","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/pde.13610","article-title":"Use of vismodegib for the treatment of multiple basal cell carcinomas in a patient with xeroderma pigmentosum","volume":"35","author":"Soura","year":"2018","journal-title":"Pediatr Dermatol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921001891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804921001891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:31:12Z","timestamp":1760733072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804921001891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":9,"alternative-id":["S0959804921001891"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.03.022","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of targeted therapy and immune checkpoint blocker in a patient with xeroderma pigmentosum presenting an aggressive angiosarcoma and a recurrent non-resectable basal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}